Coeptis Therapeutics Stock (NASDAQ:COEP), Quotes and News Summary

Q: What sector and industry does Coeptis Therapeutics (COEP) operate in?

Coeptis Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

Coeptis Therapeutics Stock (NASDAQ: COEP) stock price, news, charts, stock research, profile.

Open	$0.390
Close	$0.383
Volume / Avg.	63.976K / 266.707K
Day Range	0.380 - 0.390
52 Wk Range	0.285 - 2.190
Market Cap	$13.830M
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	55
Short Interest	0.56%
Days to Cover	1

Recent News

Collective Audience And 3 Other Stocks Under $1 Insiders Are Buying

The Dow Jones index closed lower by around 100 points on Wednesday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in penny stocks can consider this a factor in their overall investment or trading decision.

Avi Kapoor

BioRestorative Therapies And 3 Other Stocks Under $3 Insiders Are Buying

The Dow Jones closed lower by over 150 points on Thursday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in penny stocks can consider this a factor in their overall investment or trading decision.

Lisa Levin

Why Inventiva Shares Are Trading Higher By 24%; Here Are 20 Stocks Moving Premarket

Gainers Cyxtera Technologies, Inc. (NASDAQ: CYXT) shares rose 134.6% to $0.0981 in pre-market trading after dropping 12% on Tuesday.

Lisa Levin

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Rating

4.0

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy Coeptis Therapeutics (COEP) stock?

You can purchase shares of Coeptis Therapeutics (NASDAQ: COEP) through any online brokerage.

View our list of the best stock brokerages.

Who are Coeptis Therapeutics's (COEP) competitors?

Other companies in Coeptis Therapeutics’s space includes: CERo Therapeutics Hldgs (NASDAQ:CERO), Eterna Therapeutics (NASDAQ:ERNA), Immuron (NASDAQ:IMRN), Imunon (NASDAQ:IMNN) and Dominari Holdings (NASDAQ:DOMH).

What is the target price for Coeptis Therapeutics (COEP) stock?

The latest price target for Coeptis Therapeutics (NASDAQ: COEP) was reported by Ladenburg Thalmann on Friday, September 22, 2023. The analyst firm set a price target for 3.00 expecting COEP to rise to within 12 months (a possible 733.33% upside). 3 analyst firms have reported ratings in the last year.

Current Stock Price for Coeptis Therapeutics (COEP)?

The stock price for Coeptis Therapeutics (NASDAQ: COEP) is $0.36 last updated May 9, 2024 at 5:46 PM EDT.

Does Coeptis Therapeutics (COEP) pay a dividend?

There are no upcoming dividends for Coeptis Therapeutics.

When is Coeptis Therapeutics (NASDAQ:COEP) reporting earnings?

Coeptis Therapeutics’s Q2 earnings are confirmed for Friday, August 9, 2024.

Is Coeptis Therapeutics (COEP) going to split?

There is no upcoming split for Coeptis Therapeutics.

What sector and industry does Coeptis Therapeutics (COEP) operate in?

Coeptis Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

-

-

-

-

-

-

-

-

-

-

-

-

-

-